These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37357981)
21. Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB. McCullough KB; Titus A; Reardon K; Conyers S; Dougherty JD; Ge X; Garbow JR; Dickson P; Yuede CM; Maloney SE J Neurodev Disord; 2024 Apr; 16(1):16. PubMed ID: 38632525 [TBL] [Abstract][Full Text] [Related]
22. An Engineered Douek AM; Amiri Khabooshan M; Henry J; Stamatis SA; Kreuder F; Ramm G; Änkö ML; Wlodkowic D; Kaslin J Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073041 [TBL] [Abstract][Full Text] [Related]
23. An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA. Wijburg FA; Aiach K; Chakrapani A; Eisengart JB; Giugliani R; Héron B; Muschol N; O'Neill C; Olivier S; Parker S Mol Genet Metab; 2022 Feb; 135(2):133-142. PubMed ID: 34991944 [TBL] [Abstract][Full Text] [Related]
24. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). van de Kamp JJ; Niermeijer MF; von Figura K; Giesberts MA Clin Genet; 1981 Aug; 20(2):152-60. PubMed ID: 6796310 [TBL] [Abstract][Full Text] [Related]
25. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients. Perkins KJ; Muller V; Weber B; Hopwood JJ Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012 [TBL] [Abstract][Full Text] [Related]
30. Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period. Lin HY; Chuang CK; Lee CL; Tu RY; Lo YT; Chiu PC; Niu DM; Fang YY; Chen TL; Tsai FJ; Hwu WL; Lin SJ; Chang TM; Lin SP Am J Med Genet A; 2018 Sep; 176(9):1799-1809. PubMed ID: 30070758 [TBL] [Abstract][Full Text] [Related]
31. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder. Wijburg FA; Węgrzyn G; Burton BK; Tylki-Szymańska A Acta Paediatr; 2013 May; 102(5):462-70. PubMed ID: 23336697 [TBL] [Abstract][Full Text] [Related]
32. Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome). Valstar MJ; Marchal JP; Grootenhuis M; Colland V; Wijburg FA Orphanet J Rare Dis; 2011 Jun; 6():43. PubMed ID: 21689409 [TBL] [Abstract][Full Text] [Related]
33. Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III). Muschol NM; Pape D; Kossow K; Ullrich K; Arash-Kaps L; Hennermann JB; Stücker R; Breyer SR Orphanet J Rare Dis; 2019 May; 14(1):93. PubMed ID: 31046785 [TBL] [Abstract][Full Text] [Related]
34. Natural history of Sanfilippo syndrome type A. Buhrman D; Thakkar K; Poe M; Escolar ML J Inherit Metab Dis; 2014 May; 37(3):431-7. PubMed ID: 24271936 [TBL] [Abstract][Full Text] [Related]
35. Extraneurologic symptoms as presenting signs of Sanfilippo disease. Barone R; Fiumara A; Villani GR; Di Natale P; Pavone L Pediatr Neurol; 2001 Sep; 25(3):254-7. PubMed ID: 11587884 [TBL] [Abstract][Full Text] [Related]
36. Delayed speech, hyperactivity, and coarse facies: Does Sanfilippo syndrome come to mind? Kartal A J Pediatr Neurosci; 2016; 11(3):282-284. PubMed ID: 27857809 [TBL] [Abstract][Full Text] [Related]
37. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome. Scott HS; Blanch L; Guo XH; Freeman C; Orsborn A; Baker E; Sutherland GR; Morris CP; Hopwood JJ Nat Genet; 1995 Dec; 11(4):465-7. PubMed ID: 7493035 [TBL] [Abstract][Full Text] [Related]